ASBPW Aspire Biopharma Holdings, Inc. - Warrant
NASDAQ · View on SEC EDGAR ↗ close Sep 28, 2026 10-K/10-Q Aug 13, 2026
$0.01
· of 52w range
· above low
· to high
$0.0152w low
$18.0052w high
Market Cap (MRQ)
$17.2K
P/E (TTM)
-0.0
EPS (TTM)
$-37.78
Revenue (TTM)
$97.7K
your badges
52W Range
$0–$18
Analyst Rating
·
Price Target
·
P/E
-0.0
ROE
-1032.1%
Net Profit Margin
-11314.1%
Your badge strip is empty — pin a metric anywhere on this page.
ASBPW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.01
Market Cap (MRQ)
$17.2K
P/E (TTM)
-0.0
EPS (TTM)
$-37.78
Revenue (TTM)
$97.7K
ROE (TTM)
-1032.1%
52W Range
$0–$18
ASBPW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 11, 2026 | 1-for-30 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$6.2K2025-12-31 → 2025-12-31
EPS$-16.382024-12-31 → 2025-12-31
Net margin-11314.1%2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ASBPW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -0.0 | · | · | · | |
| P/S (TTM) | 0.2 | · | · | · | |
| P/B (MRQ) | 0.0 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ASBPW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | -25.0% | · | · | · | |
| Operating Margin (TTM) | -7494.8% | · | · | · | |
| EBITDA Margin | -312017.0% | · | · | · | |
| Pretax Margin | -394725.1% | · | · | · | |
| Net Profit Margin (TTM) | -11314.1% | · | · | · | |
| ROA (TTM) | -152.1%5Y avg ≈-860.5% | ≈-860.5% | · | · | |
| ROE (TTM) | -1032.1%5Y avg ≈-170.9% | ≈-170.9% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ASBPW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 8.05Y avg ≈1.0 | ≈1.0 | · | · | |
| Quick Ratio | 0.1 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ASBPW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Net Income YoY | 33.7% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ASBPW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | |
| Inventory Turnover | 0.0 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 |
|---|---|---|
| Revenue | $6.2K | |
| Cost of Revenue | $6.3K | |
| Gross Profit | $-116 | |
| R&D Expense | $923.9K | |
| SG&A Expense | $18M | |
| Operating Expenses | $19M | |
| Operating Income | $-19M | |
| Other Non-op | $-5M | |
| Pretax Income | $-24M | |
| Net Income | $-24M | |
| EPS (Diluted) | $-16.38 | |
| Shares (Basic) | 1,494,956 | |
| Shares (Diluted) | 1,494,956 | |
| EBITDA | $-19M |
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $1M | |
| Inventory | $253.2K | |
| Prepaid Expense | $55.1K | |
| Current Assets | $1M | |
| Total Assets | $1M | |
| Accounts Payable | $1M | |
| Accrued Liabilities | $1M | |
| Current Liabilities | $8M | |
| Total Liabilities | $8M | |
| Common Stock | $12 | |
| Paid-in Capital | $21M | |
| Retained Earnings | $-27M | |
| Stockholders' Equity | $-6M | |
| Liabilities + Equity | $1M | |
| Shares Outstanding | 117,780 |
Cash Flow
| Metric | Trend | 2025 |
|---|---|---|
| Stock-based Comp | $14M | |
| Operating Cash Flow | $-5M | |
| Financing Cash Flow | $6M | |
| Net Change in Cash | $1M |
Profitability
| Metric | Trend | 2025 |
|---|---|---|
| Gross Margin | -1.9% | |
| Operating Margin | -312017.0% | |
| Net Margin | -394725.1% | |
| Pretax Margin | -394725.1% | |
| EBITDA Margin | -312017.0% | |
| ROA | -3353.2% | |
| ROE | 306.1% |
Liquidity & Solvency
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 0.2 | |
| Quick Ratio | 0.1 |
Efficiency
| Metric | Trend | 2025 |
|---|---|---|
| Asset Turnover | 0.0 | |
| Inventory Turnover | 0.0 |
Per Share
| Metric | Trend | 2025 |
|---|---|---|
| Book Value / Share | $-1.80 | |
| Revenue / Share | $0.00 | |
| Cash Flow / Share | $-3.29 | |
| Cash / Share | $0.28 | |
| EPS (TTM) | $-16.38 |
Valuation (TTM)
| Metric | Trend | 2025 |
|---|---|---|
| Revenue TTM | $6.2K | |
| Net Income TTM | $-24M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue | $63.1K | $28.4K | $4.3K | $1.9K | |
| Cost of Revenue | $50.8K | $22.6K | $5.3K | $1.1K | |
| Gross Profit | $-30.1K | $5.8K | $-1.0K | $884 | |
| R&D Expense | $233.5K | $296.7K | $100.0K | $207.9K | |
| SG&A Expense | $970.2K | $1M | $2M | $513.0K | |
| Operating Expenses | $3M | $2M | $2M | $1M | |
| Operating Income | $-3M | $-2M | $-2M | $-1M | |
| Interest Income | $56.7K | $5.0K | · | · | |
| Other Non-op | $1M | $-2M | $-3M | $-705.0K | |
| Pretax Income | $-1M | $-3M | · | · | |
| Net Income | $-1M | $-3M | $-5M | $-2M | |
| EPS (Basic) | $-1.22 | $-20.57 | · | $-0.04 | |
| EPS (Diluted) | $-1.22 | $-20.57 | $-15.95 | $-0.04 | |
| Shares (Basic) | 1,037,874 | 156,685 | · | 49,525,970 | |
| Shares (Diluted) | 1,037,874 | 156,685 | · | 49,525,970 | |
| EBITDA | $-3M | $-2M | · | $-1M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $6M | $1M | $2M | |
| Inventory | $288.4K | $370.0K | $253.2K | $35.4K | |
| Prepaid Expense | $1M | $890.1K | $55.1K | $419.4K | |
| Current Assets | $13M | $7M | $1M | $2M | |
| Total Assets | $14M | $7M | $1M | $2M | |
| Accounts Payable | $972.1K | $857.9K | $1M | $1M | |
| Accrued Liabilities | $714.1K | $441.6K | $1M | $266.9K | |
| Current Liabilities | $2M | $3M | $8M | $14M | |
| Total Liabilities | $2M | $3M | $8M | $14M | |
| Common Stock | $129 | $17 | $353 | $5.0K | |
| Paid-in Capital | $44M | $34M | $21M | $11M | |
| Retained Earnings | $-32M | $-30M | $-27M | $-23M | |
| Stockholders' Equity | $12M | $4M | $-6M | $-11M | |
| Liabilities + Equity | $14M | $7M | $1M | $2M | |
| Shares Outstanding | 1,295,234 | 167,470 | 3,533,408 | 49,525,970 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Stock-based Comp | $144.1K | $13.4K | $0 | $0 | |
| Operating Cash Flow | $-2M | $-3M | $-927.8K | $-1M | |
| Stock Issued | $9M | $9M | · | · | |
| Net Stock Activity | · | $9M | · | · | |
| Financing Cash Flow | $8M | $8M | $-16.5K | $3M | |
| Net Change in Cash | $6M | $5M | $-944.4K | $2M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Gross Margin | -47.7% | 20.3% | · | 45.5% | |
| Operating Margin | -4244.1% | -5806.0% | · | -59015.8% | |
| Net Margin | -2009.6% | -11367.0% | · | -95337.1% | |
| Pretax Margin | -2009.6% | -11367.0% | · | · | |
| EBITDA Margin | -4244.1% | -5806.0% | · | -59015.8% | |
| ROA | -17.5% | -71.0% | · | -40.8% | |
| ROE | -118.5% | 157.8% | · | 20.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Current Ratio | 8.0 | 2.3 | · | 0.2 | |
| Quick Ratio | 7.2 | 1.9 | · | 0.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.1 | · | 0.1 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Book Value / Share | $9.08 | $23.10 | · | $-0.23 | |
| Revenue / Share | $0.06 | $0.18 | · | $0.00 | |
| Cash Flow / Share | · | $-19.39 | · | · | |
| Cash / Share | $9.39 | $34.97 | · | $0.04 | |
| EPS (TTM) | $-37.78 | $-84.75 | · | $-554.99 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue TTM | $97.7K | · | · | · | |
| Net Income TTM | $-11M | $-12M | · | $-21M | |
| Market Cap | $25.9K | $3.3K | · | · | |
| P/E | -0.0 | -0.0 | · | · | |
| P/S | 0.3 | · | · | · | |
| P/B | 0.0 | 0.0 | · | · | |
| P / Tangible Book | 0.0 | 0.0 | · | · | |
| P / Cash Flow | · | -0.0 | · | · | |
| Earnings Yield | -188900.0% | -14125.0% | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $6.2K | · | · | · | · |
| Gross Margin % | -1.9% | · | · | · | · |
| Operating Margin % | -312017.0% | · | · | · | · |
| Net Income | $-24M | $-1M | $4M | $3M | $-25.5K |
| Diluted EPS | $-16.38 | $-1.90 | · | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 0.2 | 0.0 | 0.2 | 3.6 | · |
| Quick Ratio | 0.1 | · | · | 1.6 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 34 filers · $178K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
34
Value held
$178K
New positions
1
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 1 (0 vs prior Q) | 3 (+3 vs prior Q) | 2 (+1 vs prior Q) | 3 (-2 vs prior Q) | +117K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Saba Capital Management, L.P. | $22,918 | 983,603 | 12.88% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $21,000 | 1,050,000 | 11.80% | Shares |
| Linden Advisors LP | $20,970 | 899,999 | 11.78% | Shares |
| ARISTEIA CAPITAL, L.L.C. | $15,879 | 681,516 | 8.92% | Shares |
| CLEAR STREET LLC | $14,799 | 331,064 | 8.32% | Shares |
| TORONTO DOMINION BANK | $10,325 | 516,245 | 5.80% | Shares |
| Sculptor Capital LP | $10,000 | 500,000 | 5.62% | Shares |
| Clear Street Group Inc. | $6,613 | 330,664 | 3.72% | Shares |
| MILLENNIUM MANAGEMENT LLC | $5,500 | 275,000 | 3.09% | Call option |
| CAAS CAPITAL MANAGEMENT LP | $5,078 | 75,000 | 2.85% | Shares |
| Clear Street Derivatives LLC | $4,738 | 106,000 | 2.66% | Shares |
| D. E. Shaw & Co., Inc. | $4,100 | 199,999 | 2.30% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $3,943 | 197,144 | 2.22% | Shares |
| Verition Fund Management LLC | $3,916 | 191,021 | 2.20% | Shares |
| Context Capital Management, LLC | $3,500 | 175,000 | 1.97% | Shares |
| Antara Capital LP | $3,427 | 207,693 | 1.93% | Shares |
| Polar Asset Management Partners Inc. | $3,228 | 138,536 | 1.81% | Shares |
| LMR Partners LLP | $2,500 | 125,000 | 1.40% | Shares |
| Periscope Capital Inc. | $2,498 | 124,924 | 1.40% | Shares |
| WHITEBOX ADVISORS LLC | $2,375 | 118,750 | 1.33% | Shares |
| JPMORGAN CHASE & CO | $2,260 | 100,000 | 1.27% | Shares |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | $2,142 | 94,792 | 1.20% | Shares |
| Limestone Investment Advisors LP | $1,500 | 75,000 | 0.84% | Shares |
| PICTON MAHONEY ASSET MANAGEMENT | $1,025 | 50,000 | 0.58% | Shares |
| Blue Owl Capital Holdings LP | $1,000 | 50,000 | 0.56% | Shares |
| Crossingbridge Advisors, LLC | $997 | 49,846 | 0.56% | Shares |
| TWO SIGMA SECURITIES, LLC | $825 | 41,269 | 0.46% | Shares |
| OMERS ADMINISTRATION Corp | $513 | 25,000 | 0.29% | Shares |
| Beacon Pointe Advisors, LLC | $400 | 20,000 | 0.22% | Shares |
| BARCLAYS PLC | $6 | 291 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $1 | 50 | 0.00% | Shares |
| Mint Tower Capital Management B.V. | $1 | 25,000 | 0.00% | Shares |
| Investors Research Corp | $0 | 10 | 0.00% | Shares |
| FLOW TRADERS U.S. LLC | $0 | 15,450 | 0.00% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| SRIRAMA Associates, LLC, Surendra Ajjarapu | Sept. 5, 2023 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026